The sentinel node biopsy procedure involves surgically removing
and analyzing one to few lymph nodes to determine whether cancer has spread
beyond the initial site and guide the extent of treatment required. Sentinel
Node Biopsy Market Growth are
primarily conducted for breast cancer staging purposes given they are less
invasive than full axillary lymph node dissections and help minimize long-term
side effects such as lymphedema in patients. Advancements in tracers and
fluorescence imaging have improved sentinel node identification rates and
optimized the procedure workflow.
The Global Sentinel Node Biopsy Market
is estimated to be valued at US$ 752.1 Mn in 2024 and is expected to exhibit a
CAGR of 7% over the forecast period 2024-2031.
Key players operating in the Sentinel Node Biopsy market are Hologic, Inc., Stryker Corporation,
Devicor Medical Products, Inc., Boston Scientific Corporation, KUBTEC Medical
Imaging, LabLogic Systems Ltd., SurgicEye GmbH, CareWise Health, Navidea
Biopharmaceuticals, Inc., Intramedical Imaging, LLC, GE Healthcare, Siemens
Healthineers, Philips Healthcare, Medtronic, and C. R. Bard, Inc..
Key Takeaways
Key players: Key players operating
in the Sentinel Node Biopsy market are Hologic, Inc., Stryker Corporation, Devicor Medical
Products, Inc., Boston Scientific Corporation, KUBTEC Medical Imaging, LabLogic
Systems Ltd., SurgicEye GmbH, CareWise Health, Navidea Biopharmaceuticals,
Inc., Intramedical Imaging, LLC, GE Healthcare, Siemens Healthineers, Philips
Healthcare, Medtronic, and C. R. Bard, Inc.
Growing demand: Rising incidence of
breast cancer globally especially in developed countries is a major factor
driving the increased demand for sentinel node biopsy procedures. Their minimally
invasive nature has led to their preference over invasive axillary lymph node
dissections.
Global expansion: Key market players are focusing on expanding their
geographical footprint especially in high growth Asian and Latin American
markets through partnerships and acquisitions. This is helping increase market
access and uptake of advanced biopsy technologies and techniques in these
regions.
Market key trends
Sentinel
Node Biopsy Market Size and Trends is gaining traction is the use of
fluorescent tracers and infrared imaging systems for sentinel node
identification. These techniques offer enhanced visualization of lymphatic drainage
pathways compared to traditional radioisotope tracers and gamma probes.
Manufacturers are gaining FDA approvals for fluorescent tracers like
indocyanine green which offer real-time intraoperative lymph node mapping with
improved accuracy and efficiency.
Porter’s
Analysis
Threat of new entrants: Sentinel
node biop market requires huge capital and expertise, posing high entry
barriers. However, expanding applications in cancer diagnosis could attract new
players.
Bargaining power of buyers: Presence
of numerous specialized clinics reduces buyers’ bargaining power, though
consolidated purchasing by large hospitals boosts it.
Bargaining power of suppliers:
Suppliers of key materials like radiopharmaceuticals hold some influence over
pricing due to specialized expertise required. However, entry of alternatives
temper their power.
Threat of new substitutes: Emerging
non-invasive diagnostic techniques pose threat, though sentinel node biop
remains standard of care for staging many cancers.
Competitive rivalry: Market
populated by global specialists with expanding regional reach and new portable
devices, intensifying competition on quality and pricing.
The United States accounts for over 40% of the global sentinel node biop market
value owing to large cancer patient pools, favourable reimbursements, and
widespread healthcare accessibility. Major companies have strong presence to
cater US demand.
The Asia Pacific region excluding Japan is witnessing the fastest growth in the
sentinel node biop market led by expanding healthcare infrastructure, rising
cancer incidence, and increasing diagnostics adoption in populous nations like
China and India.
Explore More Related Article On- Wine
Market
For Deeper Insights, Find the Report in the Language that
You want.
About Author:
Vaagisha
brings over three years of expertise as a content editor in the market
research domain. Originally a creative writer, she discovered her passion for
editing, combining her flair for writing with a meticulous eye for detail. Her
ability to craft and refine compelling content makes her an invaluable asset in
delivering polished and engaging write-ups.
(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)
